nodes	percent_of_prediction	percent_of_DWPC	metapath
Tobramycin—Framycetin—CXCR4—melanoma	0.0445	1	CrCbGaD
Tobramycin—Chest discomfort—Docetaxel—melanoma	0.00418	0.00437	CcSEcCtD
Tobramycin—Cough—Vemurafenib—melanoma	0.00415	0.00434	CcSEcCtD
Tobramycin—Bone disorder—Docetaxel—melanoma	0.00409	0.00428	CcSEcCtD
Tobramycin—Bronchospasm—Bleomycin—melanoma	0.00407	0.00426	CcSEcCtD
Tobramycin—Oropharyngeal pain—Docetaxel—melanoma	0.00406	0.00425	CcSEcCtD
Tobramycin—Myalgia—Vemurafenib—melanoma	0.00405	0.00424	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00402	0.00421	CcSEcCtD
Tobramycin—Aspartate aminotransferase increased—Dactinomycin—melanoma	0.00402	0.0042	CcSEcCtD
Tobramycin—Oliguria—Docetaxel—melanoma	0.00401	0.0042	CcSEcCtD
Tobramycin—Lacrimation increased—Docetaxel—melanoma	0.00401	0.0042	CcSEcCtD
Tobramycin—Drug interaction—Docetaxel—melanoma	0.00398	0.00417	CcSEcCtD
Tobramycin—Blood bilirubin increased—Docetaxel—melanoma	0.00391	0.00409	CcSEcCtD
Tobramycin—Hearing impaired—Docetaxel—melanoma	0.00388	0.00406	CcSEcCtD
Tobramycin—Anaphylactic shock—Vemurafenib—melanoma	0.00388	0.00406	CcSEcCtD
Tobramycin—Nervous system disorder—Vemurafenib—melanoma	0.00381	0.00398	CcSEcCtD
Tobramycin—Hypokalaemia—Carmustine—melanoma	0.0038	0.00398	CcSEcCtD
Tobramycin—Skin disorder—Vemurafenib—melanoma	0.00377	0.00394	CcSEcCtD
Tobramycin—Dehydration—Temozolomide—melanoma	0.00375	0.00393	CcSEcCtD
Tobramycin—Weight decreased—Bleomycin—melanoma	0.00374	0.00391	CcSEcCtD
Tobramycin—Dry skin—Temozolomide—melanoma	0.0037	0.00387	CcSEcCtD
Tobramycin—Phosphatase alkaline increased—Docetaxel—melanoma	0.0037	0.00387	CcSEcCtD
Tobramycin—Muscular weakness—Carmustine—melanoma	0.00368	0.00385	CcSEcCtD
Tobramycin—Hypokalaemia—Temozolomide—melanoma	0.00367	0.00384	CcSEcCtD
Tobramycin—Aspartate aminotransferase increased—Temozolomide—melanoma	0.00363	0.0038	CcSEcCtD
Tobramycin—Stomatitis—Bleomycin—melanoma	0.00359	0.00376	CcSEcCtD
Tobramycin—Muscular weakness—Temozolomide—melanoma	0.00356	0.00372	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Vemurafenib—melanoma	0.00354	0.0037	CcSEcCtD
Tobramycin—Decreased appetite—Vemurafenib—melanoma	0.00337	0.00353	CcSEcCtD
Tobramycin—Bronchitis—Temozolomide—melanoma	0.00335	0.00351	CcSEcCtD
Tobramycin—Stomatitis—Dactinomycin—melanoma	0.00335	0.00351	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Vemurafenib—melanoma	0.00335	0.00351	CcSEcCtD
Tobramycin—Upper respiratory tract infection—Temozolomide—melanoma	0.00324	0.00339	CcSEcCtD
Tobramycin—Agranulocytosis—Dactinomycin—melanoma	0.00321	0.00336	CcSEcCtD
Tobramycin—Renal failure—Carmustine—melanoma	0.00316	0.00331	CcSEcCtD
Tobramycin—Weight decreased—Temozolomide—melanoma	0.00316	0.0033	CcSEcCtD
Tobramycin—Neuropathy peripheral—Carmustine—melanoma	0.00315	0.0033	CcSEcCtD
Tobramycin—Stomatitis—Carmustine—melanoma	0.00314	0.00328	CcSEcCtD
Tobramycin—Infestation NOS—Temozolomide—melanoma	0.00311	0.00325	CcSEcCtD
Tobramycin—Infestation—Temozolomide—melanoma	0.00311	0.00325	CcSEcCtD
Tobramycin—Thrombophlebitis—Docetaxel—melanoma	0.0031	0.00324	CcSEcCtD
Tobramycin—Blood alkaline phosphatase increased—Docetaxel—melanoma	0.00308	0.00323	CcSEcCtD
Tobramycin—Body temperature increased—Vemurafenib—melanoma	0.00307	0.00321	CcSEcCtD
Tobramycin—Pharyngitis—Dactinomycin—melanoma	0.00306	0.00321	CcSEcCtD
Tobramycin—Neuropathy peripheral—Temozolomide—melanoma	0.00305	0.00319	CcSEcCtD
Tobramycin—Swelling—Docetaxel—melanoma	0.00304	0.00318	CcSEcCtD
Tobramycin—Stomatitis—Temozolomide—melanoma	0.00303	0.00317	CcSEcCtD
Tobramycin—Deafness—Docetaxel—melanoma	0.003	0.00314	CcSEcCtD
Tobramycin—Sinusitis—Temozolomide—melanoma	0.00292	0.00305	CcSEcCtD
Tobramycin—Erythema—Bleomycin—melanoma	0.00288	0.00301	CcSEcCtD
Tobramycin—Hypersensitivity—Vemurafenib—melanoma	0.00286	0.00299	CcSEcCtD
Tobramycin—Connective tissue disorder—Carmustine—melanoma	0.00284	0.00297	CcSEcCtD
Tobramycin—Renal impairment—Docetaxel—melanoma	0.00282	0.00295	CcSEcCtD
Tobramycin—Asthenia—Vemurafenib—melanoma	0.00278	0.00291	CcSEcCtD
Tobramycin—Visual impairment—Carmustine—melanoma	0.00278	0.00291	CcSEcCtD
Tobramycin—Pharyngitis—Temozolomide—melanoma	0.00277	0.0029	CcSEcCtD
Tobramycin—Urinary tract disorder—Temozolomide—melanoma	0.00276	0.00288	CcSEcCtD
Tobramycin—Pruritus—Vemurafenib—melanoma	0.00275	0.00287	CcSEcCtD
Tobramycin—Connective tissue disorder—Temozolomide—melanoma	0.00274	0.00287	CcSEcCtD
Tobramycin—Lethargy—Docetaxel—melanoma	0.00274	0.00287	CcSEcCtD
Tobramycin—Urethral disorder—Temozolomide—melanoma	0.00274	0.00286	CcSEcCtD
Tobramycin—Eye disorder—Carmustine—melanoma	0.0027	0.00282	CcSEcCtD
Tobramycin—Visual impairment—Temozolomide—melanoma	0.00269	0.00282	CcSEcCtD
Tobramycin—Erythema—Dactinomycin—melanoma	0.00269	0.00281	CcSEcCtD
Tobramycin—Ill-defined disorder—Bleomycin—melanoma	0.00267	0.0028	CcSEcCtD
Tobramycin—Anaemia—Bleomycin—melanoma	0.00266	0.00279	CcSEcCtD
Tobramycin—Diarrhoea—Vemurafenib—melanoma	0.00265	0.00278	CcSEcCtD
Tobramycin—Eye disorder—Temozolomide—melanoma	0.00261	0.00273	CcSEcCtD
Tobramycin—Tinnitus—Temozolomide—melanoma	0.0026	0.00272	CcSEcCtD
Tobramycin—Malaise—Bleomycin—melanoma	0.0026	0.00272	CcSEcCtD
Tobramycin—Leukopenia—Bleomycin—melanoma	0.00258	0.0027	CcSEcCtD
Tobramycin—Dizziness—Vemurafenib—melanoma	0.00257	0.00269	CcSEcCtD
Tobramycin—Angiopathy—Temozolomide—melanoma	0.00253	0.00265	CcSEcCtD
Tobramycin—Immune system disorder—Temozolomide—melanoma	0.00252	0.00264	CcSEcCtD
Tobramycin—Mediastinal disorder—Temozolomide—melanoma	0.00252	0.00263	CcSEcCtD
Tobramycin—Erythema—Carmustine—melanoma	0.00251	0.00263	CcSEcCtD
Tobramycin—Cough—Bleomycin—melanoma	0.00251	0.00263	CcSEcCtD
Tobramycin—Dehydration—Docetaxel—melanoma	0.0025	0.00261	CcSEcCtD
Tobramycin—Ill-defined disorder—Dactinomycin—melanoma	0.00249	0.00261	CcSEcCtD
Tobramycin—Anaemia—Dactinomycin—melanoma	0.00248	0.0026	CcSEcCtD
Tobramycin—Vomiting—Vemurafenib—melanoma	0.00247	0.00258	CcSEcCtD
Tobramycin—Dry skin—Docetaxel—melanoma	0.00246	0.00257	CcSEcCtD
Tobramycin—Chest pain—Bleomycin—melanoma	0.00245	0.00257	CcSEcCtD
Tobramycin—Myalgia—Bleomycin—melanoma	0.00245	0.00257	CcSEcCtD
Tobramycin—Rash—Vemurafenib—melanoma	0.00245	0.00256	CcSEcCtD
Tobramycin—Dermatitis—Vemurafenib—melanoma	0.00244	0.00256	CcSEcCtD
Tobramycin—Back pain—Carmustine—melanoma	0.00243	0.00255	CcSEcCtD
Tobramycin—Headache—Vemurafenib—melanoma	0.00243	0.00254	CcSEcCtD
Tobramycin—Erythema—Temozolomide—melanoma	0.00243	0.00254	CcSEcCtD
Tobramycin—Discomfort—Bleomycin—melanoma	0.00242	0.00254	CcSEcCtD
Tobramycin—Malaise—Dactinomycin—melanoma	0.00242	0.00254	CcSEcCtD
Tobramycin—Aspartate aminotransferase increased—Docetaxel—melanoma	0.00242	0.00253	CcSEcCtD
Tobramycin—Leukopenia—Dactinomycin—melanoma	0.0024	0.00252	CcSEcCtD
Tobramycin—Dysgeusia—Temozolomide—melanoma	0.00238	0.00249	CcSEcCtD
Tobramycin—Confusional state—Bleomycin—melanoma	0.00237	0.00248	CcSEcCtD
Tobramycin—Vision blurred—Carmustine—melanoma	0.00237	0.00248	CcSEcCtD
Tobramycin—Anaphylactic shock—Bleomycin—melanoma	0.00235	0.00246	CcSEcCtD
Tobramycin—Back pain—Temozolomide—melanoma	0.00235	0.00246	CcSEcCtD
Tobramycin—Anaemia—Carmustine—melanoma	0.00232	0.00243	CcSEcCtD
Tobramycin—Nausea—Vemurafenib—melanoma	0.0023	0.00241	CcSEcCtD
Tobramycin—Thrombocytopenia—Bleomycin—melanoma	0.0023	0.00241	CcSEcCtD
Tobramycin—Vision blurred—Temozolomide—melanoma	0.00229	0.0024	CcSEcCtD
Tobramycin—Myalgia—Dactinomycin—melanoma	0.00229	0.00239	CcSEcCtD
Tobramycin—Bronchospasm—Docetaxel—melanoma	0.00228	0.00239	CcSEcCtD
Tobramycin—Discomfort—Dactinomycin—melanoma	0.00226	0.00236	CcSEcCtD
Tobramycin—Ill-defined disorder—Temozolomide—melanoma	0.00225	0.00236	CcSEcCtD
Tobramycin—Leukopenia—Carmustine—melanoma	0.00225	0.00236	CcSEcCtD
Tobramycin—Anaemia—Temozolomide—melanoma	0.00225	0.00235	CcSEcCtD
Tobramycin—Anorexia—Bleomycin—melanoma	0.00224	0.00235	CcSEcCtD
Tobramycin—Angioedema—Temozolomide—melanoma	0.00222	0.00232	CcSEcCtD
Tobramycin—Malaise—Temozolomide—melanoma	0.00219	0.00229	CcSEcCtD
Tobramycin—Vertigo—Temozolomide—melanoma	0.00218	0.00228	CcSEcCtD
Tobramycin—Leukopenia—Temozolomide—melanoma	0.00218	0.00228	CcSEcCtD
Tobramycin—Thrombocytopenia—Dactinomycin—melanoma	0.00215	0.00225	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Bleomycin—melanoma	0.00214	0.00224	CcSEcCtD
Tobramycin—Chest pain—Carmustine—melanoma	0.00214	0.00224	CcSEcCtD
Tobramycin—Myalgia—Carmustine—melanoma	0.00214	0.00224	CcSEcCtD
Tobramycin—Cough—Temozolomide—melanoma	0.00212	0.00222	CcSEcCtD
Tobramycin—Paraesthesia—Bleomycin—melanoma	0.00211	0.00221	CcSEcCtD
Tobramycin—Weight decreased—Docetaxel—melanoma	0.0021	0.0022	CcSEcCtD
Tobramycin—Dyspnoea—Bleomycin—melanoma	0.0021	0.00219	CcSEcCtD
Tobramycin—Anorexia—Dactinomycin—melanoma	0.00209	0.00219	CcSEcCtD
Tobramycin—Confusional state—Carmustine—melanoma	0.00207	0.00217	CcSEcCtD
Tobramycin—Myalgia—Temozolomide—melanoma	0.00207	0.00216	CcSEcCtD
Tobramycin—Infestation NOS—Docetaxel—melanoma	0.00207	0.00216	CcSEcCtD
Tobramycin—Infestation—Docetaxel—melanoma	0.00207	0.00216	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00205	0.00215	CcSEcCtD
Tobramycin—Discomfort—Temozolomide—melanoma	0.00204	0.00214	CcSEcCtD
Tobramycin—Decreased appetite—Bleomycin—melanoma	0.00204	0.00214	CcSEcCtD
Tobramycin—Renal failure—Docetaxel—melanoma	0.00203	0.00213	CcSEcCtD
Tobramycin—Neuropathy peripheral—Docetaxel—melanoma	0.00203	0.00212	CcSEcCtD
Tobramycin—Stomatitis—Docetaxel—melanoma	0.00202	0.00211	CcSEcCtD
Tobramycin—Pain—Bleomycin—melanoma	0.00201	0.0021	CcSEcCtD
Tobramycin—Thrombocytopenia—Carmustine—melanoma	0.00201	0.0021	CcSEcCtD
Tobramycin—Confusional state—Temozolomide—melanoma	0.002	0.00209	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Dactinomycin—melanoma	0.002	0.00209	CcSEcCtD
Tobramycin—Anaphylactic shock—Temozolomide—melanoma	0.00198	0.00208	CcSEcCtD
Tobramycin—Anorexia—Carmustine—melanoma	0.00196	0.00205	CcSEcCtD
Tobramycin—Epistaxis—Docetaxel—melanoma	0.00195	0.00204	CcSEcCtD
Tobramycin—Nervous system disorder—Temozolomide—melanoma	0.00194	0.00204	CcSEcCtD
Tobramycin—Thrombocytopenia—Temozolomide—melanoma	0.00194	0.00203	CcSEcCtD
Tobramycin—Feeling abnormal—Bleomycin—melanoma	0.00194	0.00203	CcSEcCtD
Tobramycin—Agranulocytosis—Docetaxel—melanoma	0.00193	0.00202	CcSEcCtD
Tobramycin—Skin disorder—Temozolomide—melanoma	0.00193	0.00202	CcSEcCtD
Tobramycin—Decreased appetite—Dactinomycin—melanoma	0.00191	0.00199	CcSEcCtD
Tobramycin—Anorexia—Temozolomide—melanoma	0.00189	0.00198	CcSEcCtD
Tobramycin—Pain—Dactinomycin—melanoma	0.00187	0.00196	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Carmustine—melanoma	0.00187	0.00196	CcSEcCtD
Tobramycin—Urticaria—Bleomycin—melanoma	0.00187	0.00195	CcSEcCtD
Tobramycin—Rhinitis—Docetaxel—melanoma	0.00186	0.00195	CcSEcCtD
Tobramycin—Body temperature increased—Bleomycin—melanoma	0.00186	0.00194	CcSEcCtD
Tobramycin—Paraesthesia—Carmustine—melanoma	0.00184	0.00193	CcSEcCtD
Tobramycin—Pharyngitis—Docetaxel—melanoma	0.00184	0.00193	CcSEcCtD
Tobramycin—Urinary tract disorder—Docetaxel—melanoma	0.00183	0.00192	CcSEcCtD
Tobramycin—Dyspnoea—Carmustine—melanoma	0.00183	0.00191	CcSEcCtD
Tobramycin—Connective tissue disorder—Docetaxel—melanoma	0.00182	0.00191	CcSEcCtD
Tobramycin—Urethral disorder—Docetaxel—melanoma	0.00182	0.0019	CcSEcCtD
Tobramycin—Feeling abnormal—Dactinomycin—melanoma	0.00181	0.00189	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Temozolomide—melanoma	0.00181	0.00189	CcSEcCtD
Tobramycin—Gastrointestinal pain—Dactinomycin—melanoma	0.00179	0.00188	CcSEcCtD
Tobramycin—Visual impairment—Docetaxel—melanoma	0.00179	0.00187	CcSEcCtD
Tobramycin—Decreased appetite—Carmustine—melanoma	0.00178	0.00187	CcSEcCtD
Tobramycin—Paraesthesia—Temozolomide—melanoma	0.00178	0.00186	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Carmustine—melanoma	0.00177	0.00185	CcSEcCtD
Tobramycin—Dyspnoea—Temozolomide—melanoma	0.00177	0.00185	CcSEcCtD
Tobramycin—Pain—Carmustine—melanoma	0.00175	0.00184	CcSEcCtD
Tobramycin—Eye disorder—Docetaxel—melanoma	0.00173	0.00182	CcSEcCtD
Tobramycin—Body temperature increased—Dactinomycin—melanoma	0.00173	0.00181	CcSEcCtD
Tobramycin—Abdominal pain—Dactinomycin—melanoma	0.00173	0.00181	CcSEcCtD
Tobramycin—Hypersensitivity—Bleomycin—melanoma	0.00173	0.00181	CcSEcCtD
Tobramycin—Decreased appetite—Temozolomide—melanoma	0.00172	0.0018	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Temozolomide—melanoma	0.00171	0.00179	CcSEcCtD
Tobramycin—Pain—Temozolomide—melanoma	0.0017	0.00177	CcSEcCtD
Tobramycin—Feeling abnormal—Carmustine—melanoma	0.00169	0.00177	CcSEcCtD
Tobramycin—Asthenia—Bleomycin—melanoma	0.00169	0.00177	CcSEcCtD
Tobramycin—Angiopathy—Docetaxel—melanoma	0.00168	0.00176	CcSEcCtD
Tobramycin—Gastrointestinal pain—Carmustine—melanoma	0.00168	0.00176	CcSEcCtD
Tobramycin—Immune system disorder—Docetaxel—melanoma	0.00168	0.00175	CcSEcCtD
Tobramycin—Mediastinal disorder—Docetaxel—melanoma	0.00167	0.00175	CcSEcCtD
Tobramycin—Pruritus—Bleomycin—melanoma	0.00166	0.00174	CcSEcCtD
Tobramycin—Feeling abnormal—Temozolomide—melanoma	0.00163	0.00171	CcSEcCtD
Tobramycin—Body temperature increased—Carmustine—melanoma	0.00162	0.0017	CcSEcCtD
Tobramycin—Abdominal pain—Carmustine—melanoma	0.00162	0.0017	CcSEcCtD
Tobramycin—Gastrointestinal pain—Temozolomide—melanoma	0.00162	0.0017	CcSEcCtD
Tobramycin—Erythema—Docetaxel—melanoma	0.00162	0.00169	CcSEcCtD
Tobramycin—Hypersensitivity—Dactinomycin—melanoma	0.00162	0.00169	CcSEcCtD
Tobramycin—Dysgeusia—Docetaxel—melanoma	0.00158	0.00166	CcSEcCtD
Tobramycin—Urticaria—Temozolomide—melanoma	0.00158	0.00165	CcSEcCtD
Tobramycin—Asthenia—Dactinomycin—melanoma	0.00157	0.00165	CcSEcCtD
Tobramycin—Abdominal pain—Temozolomide—melanoma	0.00157	0.00164	CcSEcCtD
Tobramycin—Body temperature increased—Temozolomide—melanoma	0.00157	0.00164	CcSEcCtD
Tobramycin—Back pain—Docetaxel—melanoma	0.00156	0.00164	CcSEcCtD
Tobramycin—Hypersensitivity—Carmustine—melanoma	0.00151	0.00158	CcSEcCtD
Tobramycin—Diarrhoea—Dactinomycin—melanoma	0.0015	0.00157	CcSEcCtD
Tobramycin—Vomiting—Bleomycin—melanoma	0.00149	0.00156	CcSEcCtD
Tobramycin—Anaemia—Docetaxel—melanoma	0.00149	0.00156	CcSEcCtD
Tobramycin—Rash—Bleomycin—melanoma	0.00148	0.00155	CcSEcCtD
Tobramycin—Dermatitis—Bleomycin—melanoma	0.00148	0.00155	CcSEcCtD
Tobramycin—Asthenia—Carmustine—melanoma	0.00147	0.00154	CcSEcCtD
Tobramycin—Hypersensitivity—Temozolomide—melanoma	0.00146	0.00153	CcSEcCtD
Tobramycin—Leukopenia—Docetaxel—melanoma	0.00145	0.00151	CcSEcCtD
Tobramycin—Asthenia—Temozolomide—melanoma	0.00142	0.00149	CcSEcCtD
Tobramycin—Cough—Docetaxel—melanoma	0.00141	0.00148	CcSEcCtD
Tobramycin—Diarrhoea—Carmustine—melanoma	0.0014	0.00147	CcSEcCtD
Tobramycin—Pruritus—Temozolomide—melanoma	0.0014	0.00147	CcSEcCtD
Tobramycin—Nausea—Bleomycin—melanoma	0.0014	0.00146	CcSEcCtD
Tobramycin—Vomiting—Dactinomycin—melanoma	0.00139	0.00146	CcSEcCtD
Tobramycin—Rash—Dactinomycin—melanoma	0.00138	0.00145	CcSEcCtD
Tobramycin—Chest pain—Docetaxel—melanoma	0.00138	0.00144	CcSEcCtD
Tobramycin—Myalgia—Docetaxel—melanoma	0.00138	0.00144	CcSEcCtD
Tobramycin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00137	0.00143	CcSEcCtD
Tobramycin—Dizziness—Carmustine—melanoma	0.00136	0.00142	CcSEcCtD
Tobramycin—Diarrhoea—Temozolomide—melanoma	0.00136	0.00142	CcSEcCtD
Tobramycin—Confusional state—Docetaxel—melanoma	0.00133	0.00139	CcSEcCtD
Tobramycin—Anaphylactic shock—Docetaxel—melanoma	0.00132	0.00138	CcSEcCtD
Tobramycin—Dizziness—Temozolomide—melanoma	0.00131	0.00137	CcSEcCtD
Tobramycin—Vomiting—Carmustine—melanoma	0.0013	0.00137	CcSEcCtD
Tobramycin—Nausea—Dactinomycin—melanoma	0.0013	0.00136	CcSEcCtD
Tobramycin—Rash—Carmustine—melanoma	0.00129	0.00135	CcSEcCtD
Tobramycin—Nervous system disorder—Docetaxel—melanoma	0.00129	0.00135	CcSEcCtD
Tobramycin—Dermatitis—Carmustine—melanoma	0.00129	0.00135	CcSEcCtD
Tobramycin—Thrombocytopenia—Docetaxel—melanoma	0.00129	0.00135	CcSEcCtD
Tobramycin—Headache—Carmustine—melanoma	0.00129	0.00135	CcSEcCtD
Tobramycin—Skin disorder—Docetaxel—melanoma	0.00128	0.00134	CcSEcCtD
Tobramycin—Vomiting—Temozolomide—melanoma	0.00126	0.00132	CcSEcCtD
Tobramycin—Anorexia—Docetaxel—melanoma	0.00126	0.00132	CcSEcCtD
Tobramycin—Rash—Temozolomide—melanoma	0.00125	0.00131	CcSEcCtD
Tobramycin—Dermatitis—Temozolomide—melanoma	0.00125	0.00131	CcSEcCtD
Tobramycin—Headache—Temozolomide—melanoma	0.00124	0.0013	CcSEcCtD
Tobramycin—Nausea—Carmustine—melanoma	0.00122	0.00128	CcSEcCtD
Tobramycin—Musculoskeletal discomfort—Docetaxel—melanoma	0.0012	0.00126	CcSEcCtD
Tobramycin—Paraesthesia—Docetaxel—melanoma	0.00118	0.00124	CcSEcCtD
Tobramycin—Nausea—Temozolomide—melanoma	0.00118	0.00123	CcSEcCtD
Tobramycin—Dyspnoea—Docetaxel—melanoma	0.00118	0.00123	CcSEcCtD
Tobramycin—Decreased appetite—Docetaxel—melanoma	0.00115	0.0012	CcSEcCtD
Tobramycin—Gastrointestinal disorder—Docetaxel—melanoma	0.00114	0.00119	CcSEcCtD
Tobramycin—Pain—Docetaxel—melanoma	0.00113	0.00118	CcSEcCtD
Tobramycin—Feeling abnormal—Docetaxel—melanoma	0.00109	0.00114	CcSEcCtD
Tobramycin—Gastrointestinal pain—Docetaxel—melanoma	0.00108	0.00113	CcSEcCtD
Tobramycin—Abdominal pain—Docetaxel—melanoma	0.00104	0.00109	CcSEcCtD
Tobramycin—Body temperature increased—Docetaxel—melanoma	0.00104	0.00109	CcSEcCtD
Tobramycin—Hypersensitivity—Docetaxel—melanoma	0.000972	0.00102	CcSEcCtD
Tobramycin—Asthenia—Docetaxel—melanoma	0.000946	0.00099	CcSEcCtD
Tobramycin—Pruritus—Docetaxel—melanoma	0.000933	0.000976	CcSEcCtD
Tobramycin—Diarrhoea—Docetaxel—melanoma	0.000902	0.000944	CcSEcCtD
Tobramycin—Dizziness—Docetaxel—melanoma	0.000872	0.000913	CcSEcCtD
Tobramycin—Vomiting—Docetaxel—melanoma	0.000839	0.000878	CcSEcCtD
Tobramycin—Rash—Docetaxel—melanoma	0.000832	0.00087	CcSEcCtD
Tobramycin—Dermatitis—Docetaxel—melanoma	0.000831	0.000869	CcSEcCtD
Tobramycin—Headache—Docetaxel—melanoma	0.000826	0.000865	CcSEcCtD
Tobramycin—Nausea—Docetaxel—melanoma	0.000783	0.00082	CcSEcCtD
